Colistin Dosage Guide: Research Protocols, Timing & Reconstitution

Standard Dosage Range

Research dosing range: 2.5–5 mg/kg per day (colistin base activity), divided q8–12h OR 75,000–150,000 IU/kg per day divided q8-12h (CMS)

Educational reference only

These dosage ranges are derived from preclinical research and community protocols. No human clinical dose-ranging trials have established therapeutic doses for most research peptides. Always consult a qualified healthcare provider before starting any peptide protocol.

Dosage by Use Case

Pneumonia (Ventilator-Associated, HAP)

2.5–3 mg/kg CBA/day (adjust for renal function)Divided q8-12h

Duration

7-21 days

Aerosolized colistin (CMS 2-4 million IU q8-12h) may be added for synergistic effect. Loading dose (9 million IU CMS) may be considered in critically ill patients with normal renal function.

Bloodstream Infection (BSI)

2.5–5 mg/kg CBA/day (adjust for renal function)Divided q8-12h

Duration

10-14 days

Higher doses may be needed for carbapenem-resistant organisms with elevated MICs to colistin. Consider combination therapy.

Urinary Tract Infection (UTI)

1.5-2.5 mg/kg CBA/day (adjust for renal function)Divided q12h

Duration

7-14 days

Lower doses may be sufficient for uncomplicated UTIs, especially if the organism is susceptible. Consider local antibiotic resistance patterns.

Cystic Fibrosis Pulmonary Exacerbations

2.5–3 mg/kg CBA/day (adjust for renal function)Divided q8-12h

Duration

14-21 days

Aerosolized colistin is commonly used as maintenance therapy. Monitor renal function closely.

Multidrug-Resistant Acinetobacter Infections

3-5 mg/kg CBA/day (adjust for renal function)Divided q8h

Duration

10-21 days

Combination therapy is almost always required due to high resistance rates. Consider tigecycline, meropenem, or sulbactam.

Timing & Frequency

Colistin is typically administered intravenously over 30-60 minutes to minimize potential for nephrotoxicity. Ensure adequate hydration during therapy. Peak and trough levels are not routinely monitored, but may be considered in patients with fluctuating renal function or prolonged therapy. Administer at evenly spaced intervals (q8h or q12h) to maintain consistent drug concentrations.

Cycle Guidance

Colistin is usually reserved for short-term treatment of acute infections. Prolonged use is associated with increased risk of nephrotoxicity and neurotoxicity. Monitor renal function at least every other day, and more frequently if renal impairment is present. Consider alternative agents or dose de-escalation if possible.

Reconstitution Reference

Quick reference for reconstituting Colistin. For custom vial sizes and concentrations, use the Reconstitution Calculator.

Common Vial Size	150 mg colistin base activity (CBA) per vial (Coly-Mycin M injectable)
BAC Water Volume	2 mL sterile water for injection for a concentration of 75 mg CBA/mL. Further dilute in 50-100 mL 0.9% sodium chloride or 5% dextrose solution.
Concentration & Draw	Variable depending on dilution. Consult pharmacist for specific calculations. Example: if reconstituted to 75 mg CBA/mL and further diluted in 50 mL NS, a 1 mg/kg dose for a 70 kg patient would require ~0.93 mL of the 75 mg/mL concentrate, further diluted in the IV bag.
Storage	Store unreconstituted vials at controlled room temperature (20-25°C). Reconstituted solutions are stable for 24 hours at room temperature or 7 days under refrigeration (2-8°C).
Stability	Refer to manufacturer's instructions for specific stability data. Generally, reconstituted solutions should be used promptly or refrigerated. Do not use if the solution is discolored or contains particulate matter.

Use the Reconstitution Calculator → for precise injection volumes based on your exact vial size, water volume, and desired dose.

Frequently Asked Questions

What is the correct way to dose colistin?

Colistin is dosed based on colistin base activity (CBA), patient weight, and renal function. Consult with a pharmacist or infectious disease specialist for accurate dosing recommendations. Dosing varies widely based on clinical scenario and local resistance patterns. Never use outdated guidelines.

How often should renal function be monitored during colistin therapy?

Renal function should be monitored at least every other day during colistin therapy, and more frequently (e.g., daily) if the patient has pre-existing renal impairment or is receiving other nephrotoxic medications. Monitor serum creatinine, BUN, and urine output. Changes in creatinine clearance necessitate dose adjustments.

What are the common side effects of colistin?

The most common side effects of colistin are nephrotoxicity (acute kidney injury), neurotoxicity (paresthesias, dizziness, confusion, neuromuscular blockade), and local injection site reactions. Promptly report any unusual symptoms to your healthcare provider.

Can colistin be used during pregnancy?

Colistin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Limited data are available on the safety of colistin during pregnancy. Consult with an obstetrician and infectious disease specialist.

Is colistin effective against all gram-negative bacteria?

Colistin is effective against many multidrug-resistant gram-negative bacteria, including Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae. However, resistance to colistin is increasing, and susceptibility testing should be performed to guide therapy. Colistin is generally not effective against gram-positive bacteria or anaerobic bacteria.